Pharmaceutical

Jaguar Health balances ambitions for human and animal pharmaceuticals

In an exclusive interview, Jaguar Health’s CEO discussed plans for the investigation of crofelemer in human and animal studies.

Mar 13, 2024 - 00:00
Jaguar Health balances ambitions for human and animal pharmaceuticals
In an exclusive interview, Jaguar Health’s CEO discussed plans for the investigation of crofelemer in human and animal studies.
Read the original article

Tags:

Previous Article

STAT+: Eli Lilly’s anti-vanity ad campaign for Oscars

Next Article

J&J seeks label expansion for Tremfya in ulcerative colitis

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

FDA greenlights new long-term treatment option for opioid use disorder

FDA greenlights new long-term treatment option for opio...

May 24, 2023

Ocugen plans Phase I/II trials for macular disease gene therapies

Ocugen plans Phase I/II trials for macular disease gene...

Aug 22, 2023

SK Bioscience gains UK authorisation for SKYCovion Covid-19 vaccine

SK Bioscience gains UK authorisation for SKYCovion Covi...

May 30, 2023